Solumarv Den Europæiske Union - dansk - EMA (European Medicines Agency)

solumarv

marvel lifesciences ltd - insulin human - diabetes mellitus - behandling af diabetes.

Humulin NPH 100 IE/ml injektionsvæske Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

humulin nph 100 ie/ml injektionsvæske

eli lilly & co. - isophan(nhp)insulin, humant (rdna) - injektionsvæske - 100 ie/ml

Humulin NPH 100 IE/ml injektionsvæske, suspension, hætteglas Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

humulin nph 100 ie/ml injektionsvæske, suspension, hætteglas

eli lilly danmark a/s - isophan(nhp)insulin, humant (rdna) - injektionsvæske, suspension, hætteglas - 100 ie/ml

Humulin NPH KwikPen 100 IE/ml injektionsvæske Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

humulin nph kwikpen 100 ie/ml injektionsvæske

eli lilly & co. - isophan(nhp)insulin, humant (rdna) - injektionsvæske - 100 ie/ml

Humulin NPH KwikPen 100 IE/ml injektionsvæske, suspension, fyldt pen Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

humulin nph kwikpen 100 ie/ml injektionsvæske, suspension, fyldt pen

eli lilly danmark a/s - isophan(nhp)insulin, humant (rdna) - injektionsvæske, suspension, fyldt pen - 100 ie/ml

Sitagliptin Accord Den Europæiske Union - dansk - EMA (European Medicines Agency)

sitagliptin accord

accord healthcare s.l.u. - sitagliptin hydrochloride - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

BiResp Spiromax Den Europæiske Union - dansk - EMA (European Medicines Agency)

biresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

DuoResp Spiromax Den Europæiske Union - dansk - EMA (European Medicines Agency)

duoresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Accusol 35 Kalium 2 mmol/l 2 mmol/l hæmodiafiltreringsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

accusol 35 kalium 2 mmol/l 2 mmol/l hæmodiafiltreringsvæske, opløsning

nikkiso belgium - calciumchloriddihydrat, glucose, vandfri, glucosemonohydrat, kaliumchlorid, magnesiumchloridhexahydrat, natriumchlorid, natriumhydrogencarbonat - hæmodiafiltreringsvæske, opløsning - 2 mmol/l

Accusol 35 Kalium 4 mmol/l 4 mmol/l hæmodiafiltreringsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

accusol 35 kalium 4 mmol/l 4 mmol/l hæmodiafiltreringsvæske, opløsning

nikkiso belgium - calciumchloriddihydrat, glucose, vandfri, glucosemonohydrat, kaliumchlorid, magnesiumchloridhexahydrat, natriumchlorid, natriumhydrogencarbonat - hæmodiafiltreringsvæske, opløsning - 4 mmol/l